Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
CSL
Manufacturing
GSK, Sanofi, CSL nab BARDA funding for bird flu shots
CSL Seqirus, Sanofi and GSK have collectively secured $72 million in BARDA funding to boost U.S. supply of bird flu vaccines.
Angus Liu
Oct 4, 2024 1:35pm
CSL Seqirus picks up its 5th bird-flu-related BARDA award
Sep 26, 2024 3:50pm
A look at flu vaccine manufacturing and supply
Sep 6, 2024 8:42am
CSL Vifor promises marketing campaign to resolve EU probe
Jul 22, 2024 11:18am
CSL Seqirus, Sanofi and GSK begin flu vaccine shipments in US
Jul 11, 2024 11:03am
Akebia unveils IRA-driven high price for Vafseo
Jul 11, 2024 10:54am
